首页> 外国专利> PREVENTION AND INTERVENTION OF INFARCT EXPANSION FOLLOWING HEMORRHAGIC INFARCTIONS

PREVENTION AND INTERVENTION OF INFARCT EXPANSION FOLLOWING HEMORRHAGIC INFARCTIONS

机译:失血性呼吸后梗塞膨胀的预防和干预

摘要

Methods of treating a subject with myocardial infarction are provided, which include selective targeting time-dependent iron products at different phases of the infarction. It is discovered that during acute phase of myocardial infarction, ferrous iron in the form of heme accumulate, often followed by infarct expansion, and during the chronic phase, ferric iron in the form of crystals are dominant. Chelator agents specific for ferrous iron, heme or ferric iron are demonstrated in the protection of cardiomyocytes, reduction of infarct expansion, or improving cardiac remodeling following myocardial infarction. Also provided are methods for determining the presence of intramyocardial hemorrhage by measuring plasma level of cardiac troponin before and after re-vascularization or a reperfusion therapy, which can be used to guide therapeutic treatment or intervention procedures to control the hemorrhage and mitigate infarct expansion.
机译:提供了用心肌梗塞治疗受试者的方法,包括在梗死的不同阶段的选择性靶向时间依赖性铁产物。 可以发现,在心肌梗死的急性期间,血红素形式的亚铁中的铁铁常常随后进行梗塞膨胀,并且在慢性相期间,晶体形式的铁铁是显性的。 对亚铁,血红素或铁铁特异的螯合剂剂被证明在保护心肌细胞,减少梗塞膨胀,或改善心肌梗死后的心脏重塑。 还提供了通过测量再血管形成之前和再灌注治疗之前和之后的心肌肌钙蛋白的血浆水平来确定肌动脉内出血存在的方法,或者可用于指导治疗治疗或干预程序以控制出血和减轻梗塞膨胀。

著录项

  • 公开/公告号WO2021188984A1

    专利类型

  • 公开/公告日2021-09-23

    原文格式PDF

  • 申请/专利权人 CEDARS-SINAI MEDICAL CENTER;

    申请/专利号WO2021US23292

  • 发明设计人 DHARMAKUMAR ROHAN;

    申请日2021-03-19

  • 分类号A61B5/02;A61K31/16;A61K45/06;

  • 国家 US

  • 入库时间 2022-08-24 21:14:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号